Monoclonal antibody targeting of anti-cancer agents: Mühlbock memorial lecture.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000276:immunology; D000918:Antibody Specificity; D000951:Antigens, Neoplasm / Q000276:immunology; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001666:Binding Sites, Antibody; D002272:Carcinoembryonic Antigen / Q000276:immunology; D003110:Colonic Neoplasms / Q000276:immunology; D006241:Haptens / Q000276:immunology; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D009369:Neoplasms / Q000532:radiotherapy; D012276:Ricin / Q000627:therapeutic use; D012513:Sarcoma, Experimental / Q000188:drug therapy; D012709:Serum Albumin / Q000276:immunology
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen; D006241:Haptens; D007457:Iodine Radioisotopes; D012709:Serum Albumin; D012276:Ricin; D008727:Methotrexate